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UNIT A19.1MRI of the Male Pelvis
MRI provides comprehensive information on many male pelvic diseases such as prostate
cancer and bladder cancer as well as lymph nodes and bone metastases. The authors
employ a set protocol incorporating T1- and T2-weighted sequences including transverse
and sagittal data acquisitions, and the routine use of intravenous gadolinium.
BASIC
PROTOCOL
IMAGING THE MALE PELVIS
The sequences described herein are based on the authors’ experience with a Siemens 1.5 T
Vision scanner, but are expected to be equally applicable to machines from other
manufacturers.
Scanning a patient or volunteer is a joint effort among technologists, nurses, and
physicians, with the technologist normally responsible for following proper scanning
protocols and techniques. Unless otherwise specified, in what follows the person to whom
directions are given is assumed to be the technologist. Table A19.1.1 lists the hardware
necessary to perform the procedure, along with appropriate parameters.
The following nine sequences comprise the imaging protocol for the male pelvis. This
protocol employs multiple data acquisitions and serial post-gadolinium imaging. Most
sequences require the patient to be able to suspend respiration for ∼25 sec. It is imperative
that there is clear communication between the technologist and the patient throughout the
exam. This protocol results in consistent, reproducible image quality that is effective for
evaluating the full spectrum of male pelvic diseases.
NOTE: Be sure that technologists and nurses have immediate access to any emergency
equipment that may be relevant to a given study, or that may be needed for a particular
patient, such as crash carts or oxygen.
Materials
Normal saline (0.9% NaCl, sterile), 40 ml minimum
Extravascular contrast agent (e.g., Magnevist, Omniscan, or Prohance), volume by
patient weight
Set up patient and equipment
1. Interview the patient to assess for contraindications such as cardiac pacemaker,
implanted mechanical devices, and/or ferromagnetic materials. Also, determine if the
patient will need sedation medication necessitating the use of appropriate monitoring
equipment.
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Table A19.1.1 Equipment Specifications Needed to Perform the Following
Imaging Sequences
Coil type Circularly polarized body phased array coil
Manufacturer and system type Siemens, Vision
Field strength 1.5 T
Gradient coil strength 24 mT/m (or whatever the system permits)
Knee cushion Yes
Use of contrast agents Yes
Pulse oximeter If patient requires sedation
Power injector Yes
Normal saline Yes




A screening form is signed by each patient or legal guardian prior to bringing the patient
into the exam area.
The presence of ferromagnetic materials may be a health hazard to the patient while in the
magnetic field and/or adversely affect image quality. To determine the safety of scanning,
such ferromagnetic materials, see Shellock (1996).
The presence of ferromagnetic materials in the globe of the eye is contraindicated for MRI.
Patients with prior metal exposure to the eye should have plain x-rays of the orbital area
to ensure that all metal has been removed prior to placing them in the magnetic field.
2. Request the patient to change into a gown and remove all personal effects such as,
jewelry, hearing aids, glasses, etc., prior to entering the MRI scan room. All personal
belongings should be secured during the examination. If the procedure is a research
protocol, have the patient sign any necessary consent forms.
3. Explain the procedure to the patient and record relevant clinical history. Ensure that
the patient understands what is expected and ask them if they have any questions;
answer appropriately.
4. Fill a 20-ml syringe with normal saline and attach to saline filled extension tubing
(35 in.). Obtain i.v. access utilizing a 22-G angiocatheter and attach saline prepared
extension tubing and syringe. This will allow you to flush the extension tubing while
the patient waits to be imaged. In cases in which a power injector is not available,
this will allow you to prepare for bolus injection. Secure the position of the angio-
catheter with tegraderm or tape.
Obtaining i.v. access prior to entering the scan room will promote patient throughput and
eliminate “dead” time of starting the i.v. while the patient is on the exam table. Follow
power injector manufacturer guidelines with regard to appropriate gauge needle/angio-
catheter to be used; this will depend on chosen injection/flow rates.
IMPORTANT NOTE: If there is no access to a power injector, you will still be able to
perform dynamic imaging as the extension tubing will allow the saline syringe to be placed
at the foot of the patient table during pre-contrast imaging. In this case, you will need to
draw-up contrast in another syringe. When you are ready to bolus inject the contrast agent,
simply disconnect the saline syringe and connect the syringe filled with contrast agent;
once you have injected the bolus of contrast agent, reconnect the saline syringe and bolus
an appropriate volume of flush, usually ∼10 ml. Alternatively, to eliminate the need of
switching syringes, incorporate the use of a 3-way stopcock.
5. Set up the exam room by securing the circularly polarized (CP)-body array coil onto
the table and providing a clean exam table.
6. Set-up the power injector as specified by the manufacturer. A minimum of 40 ml
normal saline should be drawn-up to ensure sufficient saline is available to keep the
vein open (KVO) throughout the exam. To determine the amount of contrast agent to
be used, reference the contrast agent packet insert and draw-up the amount indicated
per killogram of patient weight. There is no need to double dose.
7. Escort the patient to the MR examination room and ask them to lie down accordingly
with respect to the exam to be performed. Connect the extension tubing secured to
the syringe to the power injector extension tubing. Review the following items with
the patient:
a. Provide earplugs or headphones to the patient to minimize the loud knocking noise
that will be produced by the gradients but ensure them that they will still be able
to hear you.
b. Provide the patient with a safety squeeze-bulb and demonstrate how it works;
explain to the patient when to use the squeeze-bulb (i.e., if they need assistance
during the exam).




c. Explain to the patient that you will be talking to them between imaging sequences
that will be when the loud knocking noise stops. Additionally, review breath-hold-
ing instructions with the patient.
d. Explain to the patient that it is imperative that they remain motionless during the
loud knocking noise to ensure good results; also explain that they should not
reposition their body between imaging sequences.
e. Position a support under the patient’s knees to enhance patient comfort.
f. Provide the patient with an approximate time that the examination will take.
8. Secure the top portion of the CP-body array coil to prevent it from moving side-to-side
during breath-holding imaging sequences. Usually straps are provided by the manu-
facturer that are directly attached to the coil.
9. Using the laser light center the patient’s pelvis to the coil. Position the CP-body array
coil to include the entire pelvis and as much of the abdomen as possible. Do not
sacrifice coil coverage at the bottom of the pelvis to include more of the abdomen.
10. Advance the patient table to isocenter.
11. Program the power injector for a contrast agent and saline injection rate of 2 ml/sec. Total
volume of saline following contrast agent injection should be programmed for 10 ml.
Program a scan delay of 25 sec (contrast agent is injected, scan is initiated 25 sec after
contrast agent and saline are delivered). Arm the power injector and keep the vein open.
Do not inject the contrast agent at this time!
Sequence 1: Three-plane positioning scout (breath-hold)
12. To validate the patient’s position and to have a reference to prescribe successive
imaging sequences, acquire a three-plane orthogonal scout sequence. See Table
A19.1.2 for specific parameters.
Most MR scanners can be programmed to acquire the scout automatically after coil tuning
or after the patient has been placed in isocenter (for systems that do not require tuning).
13. Instruct the patient to take in a deep breath and exhale, take in another deep breath
and hold it. Initiate the scan.
Sequence 2: Transverse gradient echo (mid-abdomen)
14. Display both the coronal and transverse scout images in two separate quadrants on
the scan monitor. Change imaging parameters to those listed in Table A19.1.3.
Position slices on the coronal scout ensuring that the mid-abdomen is covered.
15. Instruct the patient to take in a deep breath and exhale, take in another deep breath
and hold it. Initiate the scan.
Sequence 3: Transverse gradient echo (pelvis)
16. Display both the coronal and transverse scout images in two separate quadrants on
the scan monitor. Change imaging parameters to those listed in Table A19.1.4.
Position slices on the coronal scout ensuring that the pelvis is covered.
17. Instruct the patient to take in a deep breath and exhale, take in another deep breath
and hold it. Initiate the scan.
Sequence 4: Transverse gradient echo with fat suppression
18. Display the coronal image and the transverse scout image in two separate quadrants
on the scan monitor. Change imaging parameters to those listed in Table A19.1.5.
Position slices to cover the pelvis.
19. Instruct the patient to take in a deep breath and exhale, take in another deep breath
and hold it.
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Table A19.1.3 Imaging Parameters for Sequence 2 (Gradient Echo)
Patient position Supine
Scan type Gradient echo
Imaging plane (orientation) Transverse
Central slice or volume center Slices posted on coronal; center to
mid-abdomen
Echo time (TE) 4.5 msec
Repeat time (TR) 140 msec
Flip angle (FA) 90°
Field of view (FOVx, FOVy) 350 mm, 263 mm
Resolution (∆x, ∆y) 1.37 mm, 1.83 mm
Number of data points collected (Nx, Ny) 256, 144
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 7 mm
Number of slices 18
Slice gap 1.4 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding No 
Slice locations Centered to cover abdomen
Saturation pulses No
Slice series Interleaved
Scan time 20 sec
Table A19.1.2 Imaging Parameters for Sequence 1 (Scout Sequence)
Patient position Supine
Scan type Gradient echo
Imaging plane (orientation) Sagittal, transverse, and coronal
Central slice or volume center Center to pelvis
Echo time (TE) 6 msec
Repeat time (TR) 15 msec
Flip angle (FA) 30°
Field of view (FOVx, FOVy) 450 mm, 450 mm
Resolution (∆x,∆y) 1.76 mm, 3.52 mm
Number of data points collected (Nx, Ny) 256, 128
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 10 mm
Number of slices 3
Slice gap Not applicable
Number of acquisitions (Nacq) 1
Swap read and phase encoding No 
Slice locations Not applicable
Saturation pulses Not applicable
Scan time 16 sec




Table A19.1.4 Imaging Parameters for Sequence 3 (Gradient Echo)
Patient position Supine
Scan type Gradient echo
Imaging plane (orientation) Transverse
Central slice or volume center Slices posted on coronal; center to
pelvis
Echo time (TE) 4.5 msec
Repeat time (TR) 140 msec
Flip angle (FA) 90°
Field of view (FOVx, FOVy) 350 mm, 263 mm
Resolution (∆x, ∆y) 1.37 mm, 1.83 mm
Number of data points collected (Nx, Ny) 256, 144
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 7 mm
Number of slices 18
Slice gap 1.4 mm
Number of acquisition (Nacq) 1
Swap read and phase encoding No
Slice location Centered to cover pelvis
Saturation pulses No
Slice series Interleaved
Scan time 20 sec
Table A19.1.5 Imaging Parameters for Sequence 4 (Gradient Echo with Fat
Suppression)
Patient position Supine
Scan type Gradient Echo
Imaging plane (orientation) Transverse
Central slice or volume center Slices posted on coronal; center to
pelvis
Echo time (TE) 4.1 msec
Repeat time (TR) 147.2 msec
Flip angle (FA) 80°
Field of view (FOVx, FOVy) 350 mm, 263 mm
Resolution (∆x, ∆y) 1.37 mm, 2.05 mm
Number of data points collected (Nx, Ny) 256, 128
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 10 mm
Number of slices 20
Slice gap 2 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding No




Scan time 19 sec
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20. Initiate the scan.
Sequence 5: High resolution sagittal T2-weighted turbo spin echo (Fig. A19.1.1)
21. Display both the coronal and sagittal scout images in two separate quadrants on the
scan monitor. Change imaging parameters to those listed in Table A19.1.6. Position
slices to cover the pelvis.
22. Instruct the patient to remain motionless and to breathe normally as the scan will
begin and last for ∼3 min.
Sequence 6: High resolution transverse T2-weighted turbo spin echo (Fig. A19.1.2)
23. Display both the coronal and transverse scout images in two separate quadrants on
the scan monitor. Change imaging parameters to those listed in Table A19.1.7.
Position slices to cover the pelvis.
24. Instruct the patient to remain motionless and to breathe normally as the scan will
begin and last for ∼3 min.
Sequence 7: Transverse gradient echo with fat suppression (immediate post-contrast
scan; Fig. A19.1.3)
NOTE: See patient set up section for specific instructions on preparation for contrast agent
injection. This preparation can be done prior to placing the patient in the scanner.
Figure A19.1.1 High resolution sagittal T2-weighted turbo spin
echo image.




25. Display the midline slice of the scout coronal image and the transverse scout image
in two separate quadrants on the scan monitor. Change imaging parameters to those
listed in Table A19.1.8. Position slices to cover the pelvis.
26. Explain to the patient that you will now be injecting the contrast agent and that he or
she may feel a cool sensation in his or her arm. Initiate the injection. Do not begin
scanning until the 25-sec scan delay has expired. However, breathing instructions
should be delivered when 10 sec of delay are remaining (see step 27).
If you do not have access to a power injector and are “hand” injecting follow step 26.
However, after you have completed the bolus contrast agent injection reattach the saline
filled syringe and flush with 10 ml of saline. Begin breathing instructions. After all of the
saline has been injected then proceed to initiate the scan. The process of switching syringes
must be completed as quickly as possible and thus, the suggestion of incorporating the use
of a 3-way stopcock.
27. When 15 sec after the contrast agent injection has passed, instruct the patient to take
in a deep breath and exhale, take in another deep breath and hold it.
28. Initiate the scan.
Sequence 8: Sagittal gradient echo with fat suppression (post contrast)
29. Display the transverse image and the sagittal scout image in two separate quadrants
on the scan monitor. Change imaging parameters to those listed in Table A19.1.9.
Position slices to cover the pelvis.
30. Instruct the patient to take in a deep breath and exhale, take in another deep breath
and hold it.
Table A19.1.6 Imaging Parameters for Sequence 5 (High Resolution 
T2-Weighted Turbo Spin Echo)
Patient position Supine
Scan type Turbo spin echo
Imaging plane (orientation) Sagittal
Central slice or volume center Slices posted on coronal; center to
prostate
Echo time (TE) 132 msec
Echo train length (ETL) 15
Repeat time (TR) 4902 msec
Flip angle (FA) 180°a
Field of view (FOVx, FOVy) 350 mm, 263 mm
Resolution (∆x,∆y) 0.68 mm, 0.97 mm
Number of data points collected (Nx, Ny) 512, 270
Display matrix (Dx, Dy) 512, 512
Slice thickness (∆z) 5 mm
Number of slices 19
Slice gap 1.0 mm
Number of acquisitions (Nacq) 2
Swap read and phase encoding No




Scan time 3 min, 1 sec
aThe system displays the flip angle of the refocusing pulse. The flip angle of the first pulse of this
sequence is 90°.
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Figure A19.1.2 High resolution transverse T2-weighted turbo spin echo image.
Table A19.1.7 Imaging Parameters for Sequence 6 (High Resolution
T2-Weighted Turbo Spin Echo)
Patient position Supine
Scan type Turbo spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Slices posted on coronal; center to
prostate
Echo time (TE) 132 msec
Echo time length (ETL) 15
Repeat time (TR) 4902 msec
Flip angle (FA) 180°a
Field of view (FOVx, FOVy) 350 mm, 263 mm
Resolution (∆x, ∆y) 0.68 mm, 0.97 mm
Number of data points collected (Nx, Ny) 512, 270
Display matrix (Dx, Dy) 512, 512
Slice thickness (∆z) 5 mm
Number of slices 19
Slice gap 1.0 mm
Number of acquisitions (Nacq) 2
Swap read and phase encoding No




Scan time 3 min, 1 sec
aThe system displays the flip angle of the refocusing pulse. The flip angle of the first pulse of this
sequence is 90°.




Table A19.1.8 Imaging Parameters for Sequence 7 (Gradient Echo with Fat
Suppression; Immediate Post-Contrast Scan)
Patient position Supine
Scan type Gradient echo
Imaging plane (orientation) Transverse
Central slice or volume center Slices posted on coronal; center to
pelvis
Echo time (TE) 4.1 msec
Repeat time (TR) 147.2 msec
Flip angle (FA) 80°
Field of view (FOVx, FOVy) 350 mm, 300 mm
Resolution (∆x, ∆y) 1.37 mm, 1.74 mm
Number of data points collected (Nx, Ny) 256, 172
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 8 mm
Number of slices 20
Slice gap 1.6 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding No 




Scan time 25 sec
Figure A19.1.3 Transverse gradient echo with fat suppression immediate post contrast image.
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Table A19.1.10 Imaging Parameters for Sequence 9 (Gradient Echo with Fat
Suppression)
Patient position Supine
Scan type Gradient echo
Imaging plane (orientation) Transverse
Central slice or volume center Slices posted on coronal; center to
mid-abdomen
Echo time (TE) 4.1 msec
Repeat time (TR) 147.2 msec
Flip angle (FA) 80°
Field of view (FOVx, FOVy) 350 mm, 263 mm
Resolution (∆x, ∆y) 1.37 mm, 2.74 mm
Number of data points collected (Nx, Ny) 256, 96
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 8-10 mm
Number of slices 20
Slice gap 1.6-2 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding No




Scan time 14 sec
Table A19.1.9 Imaging Parameters for Sequence 8 (Gradient Echo with Fat
Suppression)
Patient position Supine
Scan type Gradient echo
Imaging plane (orientation) Sagittal
Central slice or volume center Slices posted on transverse; center
to pelvis
Echo time (TE) 4.1 msec
Repeat time (TR) 147.2 msec
Flip angle (FA) 80°
Field of view (FOVx, FOVy) 350 mm, 300 mm
Resolution (∆x, ∆y) 1.37 mm, 1.74 mm
Number of data points collected (Nx, Ny) 256, 172
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 8-10 mm
Number of slices 20
Slice gap 1.6-2 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding No




Scan time 25 sec




31. Initiate the scan.
Sequence 9: Transverse gradient echo with fat suppression (post contrast;
mid-abdomen)
32. Display the coronal image and the transverse scout image in two separate quadrants
on the scan monitor. Change imaging parameters to those listed in Table A19.1.10.
Position slices to cover the mid-abdomen.
33. Instruct the patient to take in a deep breath and exhale, take in another deep breath
and hold it.
34. Initiate the scan
COMMENTARY
Background Information
The major indication for MRI of the male
pelvis is for the investigation of prostate cancer
(Mirowitz et al., 1994; Nunes et al., 1995;
Hricak et al., 1994; Schnall et al., 1991; Huch
Boni et al., 1996). The male pelvis MR protocol
is designed to evaluate the prostate gland and
the most common forms of metastases, lymph
nodes, and bone metastases.
Critical Parameters and
Troubleshooting
High-resolution T2-weighted images are
critical for the detection of prostate cancer (Mi-
rowitz et al., 1994; Nunes et al., 1995; Hricak
et al., 1994; Schnall et al., 1991; Huch Boni et
al., 1996). Using local receiver coils helps
achieve high spatial resolution imaging. The
above described protocol employs a phased
array multicoil. Other investigators have used
endorectal coils.
Anticipated Results
The non-contrast T1-weighted spoiled gra-
dient echo images of the upper abdomen and
pelvis are used to evaluate for lymph nodes.
Five millimeter thick transverse and sagittal
T2-weighted images are the principal technique
to evaluate the prostate and seminal vesicles.
The post-gadolinium T1-weighted fat sup-
pressed spoiled gradient echo sequence is the
most consistent sequence to detect bony metas-
tases. Using the above described sequences, the
detection and staging of prostate cancer is well
performed. This protocol is also effective at
evaluating other pelvis tumors such as bladder
cancer.
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Covers a number of important patient management
issues related to MR imaging, including recom-
mended safety procedures, a list of metallic implants
that have been tested for MR compatibility, and a
list of other sources on MR safety.
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